Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of phosphodiesterase-5 inhibition with Tadalafil on systemic right ventricle
2016-004291-21Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cardiovascular Malformation (CVM), transposition of the great arteries (TGA) and congenitally corrected transposition of the great arteries (ccTGA) comparing Tadalafil arm with Placebo arm (2 arms). Primary endpoint: Change in mean end-systolic right ventricular volume. Started Dec 2017; status: completed.
02
Drugs
tadalafil
03
Conditions
Cardiovascular Malformation (CVM)transposition of the great arteries (TGA)congenitally corrected transposition of the great arteries (ccTGA)
Beyond the preview
Go deeper on 2016-004291-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004291-21.